Study suggests common drug could be used to prevent certain skin cancers ANI | Updated: Apr 14, 2021 19:09 IST
Washington [US], April 14 (ANI): A new research has suggested that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skincancer caused by damage from ultraviolet-B radiation from the sun.
The findings of the study were published in the journal Cancer Prevention Research .
The study was led by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC James).
While this data was gathered from preclinical studies, senior author Sujit Basu, MD, PhD, says preliminary results in animal models are very promising and worthy of immediate further investigation through phase I human studies.
Routine Drug may be Used to Prevent Few Skin Cancers by Angela Mohan on April 14, 2021 at 12:42 PM
Skin cancer could be treated by an oral drug currently used in the clinical setting to treat neuromuscular diseases, as per the data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
While this data was gathered from preclinical studies, senior author Sujit Basu, MD, PhD, says preliminary results in animal models are very promising and worthy of immediate further investigation through phase I human studies.
Study suggests common drug could be used to prevent certain skin cancers eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Commonly used drug for neuromuscular diseases could also help prevent certain skin cancers
New data published by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an oral drug currently used in the clinical setting to treat neuromuscular diseases could also help prevent a common form of skin cancer caused by damage from ultraviolet-B (UVB) radiation from the sun.
While this data was gathered from preclinical studies, senior author Sujit Basu, MD, PhD, says preliminary results in animal models are very promising and worthy of immediate further investigation through phase I human studies.